SOX17 and pulmonary arterial hypertension: For example, in hPAECs with enhancer knockouts characteristic of PAH patients, Sirolimus and YK4279 [identified initially through high-throughput omics signatures using connectivity map (CMap)] were found to reverse Sox17 enhancer knockout mediated repression (42).